Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
The Brief Case

The Brief Case: Staphylococcus intermedius Group—Look What the Dog Dragged In

William Lainhart, Melanie L. Yarbrough, Carey-Ann D. Burnham
Alexander J. McAdam, Editor
William Lainhart
aDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William Lainhart
Melanie L. Yarbrough
aDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carey-Ann D. Burnham
aDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carey-Ann D. Burnham
Alexander J. McAdam
Boston Children's Hospital
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.00839-17
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

CASE

A 46-year-old man with a history of diabetes mellitus (type I), hypertension, congestive heart failure, and coronary artery disease presented to his primary care physician with a 3-week history of ulceration on his left, great toe. The patient reported poor compliance with blood glucose level checks and insulin use. Upon examination, the physician noted a 1- by 1.5-cm ulcer on the underside of the patient's toe. The ulcer was debrided, and a specimen for microbiological culture was collected on a flocked swab. As part of this routine work-up, the physician took a detailed history and noted that the patient lived alone with his two dogs.

A specimen Gram stain revealed no polymorphonuclear leukocytes but abundant Gram-positive cocci. The specimen was plated to sheep blood agar (SBA), chocolate agar, and MacConkey agar. The next day, abundant white beta-hemolytic colonies resembling Staphylococcus spp. were noted on the blood agar plate (BAP) and white colonies were noted on the chocolate plate. No other organisms grew in this culture. No growth was observed on the MacConkey agar plate. Upon further testing, the isolate was positive for catalase, coagulase (StaphTEX Blue; Hardy Diagnostics, Santa Maria, CA), and pyrrolidonyl arylamidase (PYR [Oxoid biochemical identification system]; Thermo Scientific, Hampshire, United Kingdom). A rapid immunochromatographic assay for penicillin-binding protein 2a was positive (PBP2a culture colony test; Alere Inc., Waltham, MA). The isolate was identified by matrix-assisted laser desorption–ionization time of flight (MALDI-TOF) mass spectrometry (MS) as Staphylococcus intermedius, a member of the S. intermedius group (SIG), with a score of 2.022. Susceptibility testing was notable for discrepant results for methicillin resistance testing by Kirby-Bauer disk diffusion: the isolate was oxacillin resistant (zone size of 17 mm) and cefoxitin susceptible (zone size of 35 mm). Otherwise, the isolate exhibited intermediate resistance to trimethoprim-sulfamethoxazole and was susceptible to vancomycin, linezolid, doxycycline, clindamycin, and erythromycin, as per Clinical and Laboratory Standards Institute document M100 (1). The patient was treated empirically with oral doxycycline and topical gentamicin cream and recovered well.

DISCUSSION

Members of the Staphylococcus intermedius group (SIG) include S. intermedius, S. pseudintermedius, and S. delphini. SIG members are common colonizers of animal mucosal surfaces, especially those of dogs (2, 3). Though it can be a component of the normal flora of the mouth, nose, and skin, the SIG, particularly S. pseudintermedius, has been implicated as a common cause of pyoderma in dogs (4, 5). In studies assessing carriage rates among dogs and cats, S. pseudintermedius was found to colonize up to 68% of dogs and up to 22% of cats, whereas S. aureus was a colonizer of up to 14% of dogs and 20% of cats (2). Other species of animal-adapted staphylococci include S. schleiferi (canine), S. felis (feline), S. lutrae, S. hyicus (porcine, coagulase variable), and S. agnetis (bovine, coagulase variable).

Members of SIG were recently separated into individual species, with the most recent taxonomic change occurring in 2005 with the creation of the S. pseudintermedius species (4). Staphylococcus delphini, originally isolated from a dolphin specimen, is associated with many types of animals, including birds, cats, horses, and other mammals (4). Despite taxonomic differences, the members of this group are difficult to differentiate phenotypically, suggesting that these species may be interchangeably misidentified (4).

In humans, SIG infections are increasingly recognized. Prior to the advent of MALDI-TOF MS for the identification of bacterial isolates from clinical specimens, SIG members were thought to uncommonly infect humans and were generally associated with dog bites (3–5), foreign-body-related infections, food poisoning, and invasive infections in immunocompromised patients (4). In one study of 39 patients with SIG infections, only 4 had a history of contact with a dog, 2 of which had a SIG member isolated from a dog bite (3). Additionally, SIG isolates were recovered from specimens, including wounds, ears, diabetic ulcers, and cutaneous ulcers (3). In other reports, the SIG was implicated in various other infections, including infective endocarditis and hardware/device infections (6). Differentiating infection from colonization when treating patients with a SIG member can be difficult. For example, the primary-specimen Gram stain of this case showed no polymorphonuclear leukocytes but abundant Gram-positive cocci, suggesting colonization with a SIG member since no inflammatory cells were present. However, this patient was treated because, clinically, this looked like an infection and the swab specimen from this open ulcer grew abundant SIG bacteria.

SIG species are very similar to S. aureus in both clinical presentation and microbiologic characteristics, including coagulase positivity, and it is likely that SIG isolates from human clinical specimens were identified as S. aureus prior to MALDI-TOF MS (6). Historically, coagulase-positive staphylococci isolated from veterinary specimens were identified as SIG, whereas these isolates were identified as S. aureus in human specimens (5). Very few systematic studies have been conducted to evaluate the ability of MALDI-TOF MS instruments to identify SIG isolates. In one study using the Vitek MS (bioMérieux, Durham, NC), four SIG isolates were tested, resulting in three isolates of S. intermedius identified to the genus level and one isolate of S. pseudintermedius identified to the species level (no MALDI-TOF database was specified in the publication). No S. delphini isolates were tested (7). In contrast to that of the Vitek MS, the performance of the Biotyper MALDI-TOF MS in identifying members of the SIG has been more rigorously evaluated. In a study focused on identification of human SIG isolates with the Bruker Biotyper MALDI-TOF MS (database version 3.0), all SIG isolates achieved a score of ≥1.7 (genus-level identification), and 78.9% (15/19) of the S. delphini isolates, 76.5% (13/17) of the S. intermedius isolates, and 89.5% (145/162) of the S. pseudintermedius isolates achieved a score of ≥2.0 (species-level identification) (8).

Like S. aureus, SIG species are catalase positive, coagulase positive, Gram-positive cocci in clusters (Table 1). Like S. aureus, SIG isolates may grow on mannitol salt agar, which is often used in S. aureus colonization screening cultures, and many will ferment d-mannitol (Table 1), producing a yellow colony that might be suggestive of S. aureus (Fig. 1F) (4). However, colonies of SIG isolates can be whiter than S. aureus on SBA plates (Fig. 1A and C). Additionally, SIG isolates are beta-hemolytic, with a double zone of hemolysis (see the clearing and darkening of the agar in Fig. 1D), compared to S. aureus, which has a single zone of beta-hemolysis (Fig. 1B). Despite both being coagulase positive (4), SIG isolates exhibit a slightly different result from S. aureus isolates in latex agglutination testing (i.e., see the more chunky and stringy clumping in Fig. 2A and B), and instances of coagulase-positive S. pseudintermedius misidentification due to negative latex agglutination tests have been documented (4). This misidentification can happen because current Staphylococcus latex agglutination tests employ antibodies to clumping factor and staphylococcal protein A (product of the spa gene) (4). Whereas all SIG species are coagulase positive, only S. intermedius has been shown to have clumping factor (Table 1). Regardless of similar morphologies and characteristics, SIG members and S. aureus can be efficiently differentiated using a variety of biochemical tests (Table 1), including the PYR test (S. aureus negative, SIG positive) (Fig. 2C) (4).

View this table:
  • View inline
  • View popup
TABLE 1

Biochemical characteristics used to differentiate Staphylococcus aureus from animal-adapted, coagulase-positive Staphylococcus speciesa

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Colony morphologies of Staphylococcus intermedius group members and Staphylococcus aureus at 24 h of growth. (A) Colony morphology of S. aureus on a sheep blood agar plate. (B) Beta-hemolysis caused by S. aureus. The photo was taken using backlighting to highlight the hemolysis pattern. (C) Colony morphology of S. intermedius group on a sheep blood agar plate. (D) Double zone of beta-hemolysis caused by an S. intermedius group member. The photo was taken using backlighting to highlight the hemolysis pattern. (E) Growth of an S. intermedius group member on a Spectra MRSA chromogenic agar plate (Remel Microbiology Products, Lenexa, KS). (F) Growth of an S. intermedius group member on mannitol salt agar (Remel Microbiology Products).

FIG 2
  • Open in new tab
  • Download powerpoint
FIG 2

Biochemical characteristics of Staphylococcus intermedius group members compared to those of Staphylococcus aureus, and susceptibility testing for S. intermedius group members. (A) Latex agglutination test (coagulase) result for S. aureus; (B) latex agglutination test (coagulase) result for S. intermedius group members; (C) PYR testing results for S. aureus (left, negative) and S. intermedius group members (right, positive); (D) discrepant cefoxitin (FOX 30; 26-mm diameter) and oxacillin (OX 1; 15-mm diameter) results for an S. intermedius group isolate.

Until the early 2000s, very little methicillin resistance (∼5% of isolates) was observed in veterinary SIG isolates, but methicillin resistance in SIG members is on the rise (9). As in S. aureus, methicillin resistance in SIG species is conferred by alternative penicillin binding proteins (PBPs) through the acquisition of the mecA gene, which encodes PBP2a (10). Unlike in S. aureus and the coagulase-negative staphylococci, cefoxitin has proven to be a poor surrogate indicator of methicillin resistance in SIG isolates; compared to the presence of mecA as determined by PCR, the use of cefoxitin as a surrogate indicator of methicillin resistance resulted in both major and very major errors (5). Rather, oxacillin is the appropriate surrogate for methicillin resistance in SIG isolates (Fig. 2D) (5, 10). Oxacillin susceptibility breakpoints for SIG members have been added to CLSI supplement M100 for this purpose (1). It is recognized that this testing can be problematic for some clinical laboratories, since automated identification and susceptibility systems (such as the BD Phoenix and bioMérieux Vitek 2 systems) may not routinely report an oxacillin MIC result (5) and since some clinical laboratories do not use oxacillin for antimicrobial susceptibility testing. For this reason, immunochromatographic testing for the presence of PBP2a has been studied in SIG isolates and was shown to have 100% sensitivity and 100% specificity for the detection of methicillin resistance in a comparison with mecA PCR (10), particularly when induced PBP2a testing with cefoxitin was used (5). Isolates of the SIG can also grow on chromogenic media for the detection of methicillin-resistant S. aureus (MRSA), such as Spectra MRSA agar (Remel Microbiology Products, Lenexa, KS). While SIG isolates do not produce the characteristic “denim blue” colony color of MRSA on these plates (Fig. 1E), the colonies may be considered suspicious for MRSA.

Members of the SIG are human pathogens that may be misidentified when we rely on biochemical tests such as coagulase and latex agglutination for identification of catalase-positive, Gram-positive cocci. Accurate identification has important implications for the interpretation of disk diffusion susceptibility testing, including the determination of methicillin resistance. However, identification using MALDI-TOF MS is reliable for identifying these isolates as members of the SIG.

SELF-ASSESSMENT QUESTIONS

  1. Which biochemical test can be helpful as a screen to differentiate SIG species from Staphylococcus aureus?

    1. Catalase

    2. Pyrrolidonyl arylamidase (PYR)

    3. Coagulase

    4. Ornithine decarboxylase

  2. Disk diffusion testing with which antimicrobial agent should be tested as a surrogate for methicillin resistance testing with members of the Staphylococcus intermedius group?

    1. Cefazolin

    2. Methicillin

    3. Oxacillin

    4. Cefoxitin

  3. Which staphylococcal species is not a member of the Staphylococcus intermedius group?

    1. Staphylococcus pseudintermedius

    2. Staphylococcus delphini

    3. Staphylococcus lugdunensis

    4. Staphylococcus intermedius

For answers to the self-assessment questions and take-home points, see https://doi.org/10.1128/JCM.00840-17 in this issue.

  • Copyright © 2018 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    CLSI. 2016. Performance standards for antimicrobial susceptibility testing. Document M100. Clinical and Laboratory Standards Institute, Wayne, PA.
  2. 2.↵
    1. Weese JS
    . 2012. Staphylococcal infections, p 340–348. In Greene CE (ed), Infectious diseases of the dog and cat, 4th ed. Elsevier Saunders, St. Louis, MO.
  3. 3.↵
    1. Lee J,
    2. Murray A,
    3. Bendall R,
    4. Gaze W,
    5. Zhang L,
    6. Vos M
    . 2015. Improved detection of Staphylococcus intermedius group in a routine diagnostic laboratory. J Clin Microbiol 53:961–963. doi:10.1128/JCM.02474-14.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Becker K,
    2. Skov RL,
    3. Von Eiff C
    . 2015. Staphylococcus, Micrococcus, and other catalase-positive cocci, p 354–382. In Jorgensen JH, Carroll KC, Funke G, Pfaller MA (ed), Manual of clinical microbiology, 11th ed. ASM Press, Washington, DC.
  5. 5.↵
    1. Wu MT,
    2. Burnham CA,
    3. Westblade LF,
    4. Dien Bard J,
    5. Lawhon SD,
    6. Wallace MA,
    7. Stanley T,
    8. Burd E,
    9. Hindler J,
    10. Humphries RM
    . 2016. Evaluation of oxacillin and cefoxitin disk and MIC breakpoints for prediction of methicillin resistance in human and veterinary isolates of Staphylococcus intermedius group. J Clin Microbiol 54:535–542. doi:10.1128/JCM.02864-15.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Viau R,
    2. Hujer AM,
    3. Hujer KM,
    4. Bonomo RA,
    5. Jump RL
    . 2015. Are Staphylococcus intermedius infections in humans cases of mistaken identity? A case series and literature review. Open Forum Infect Dis 2:ofv110. doi:10.1093/ofid/ofv110.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Dubois D,
    2. Grare M,
    3. Prere MF,
    4. Segonds C,
    5. Marty N,
    6. Oswald E
    . 2012. Performances of the Vitek MS matrix-assisted laser desorption ionization–time of flight mass spectrometry system for rapid identification of bacteria in routine clinical microbiology. J Clin Microbiol 50:2568–2576. doi:10.1128/JCM.00343-12.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Murugaiyan J,
    2. Walther B,
    3. Stamm I,
    4. Abou-Elnaga Y,
    5. Brueggemann-Schwarze S,
    6. Vincze S,
    7. Wieler LH,
    8. Lubke-Becker A,
    9. Semmler T,
    10. Roesler U
    . 2014. Species differentiation within the Staphylococcus intermedius group using a refined MALDI-TOF MS database. Clin Microbiol Infect 20:1007–1015. doi:10.1111/1469-0691.12662.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Bemis DA,
    2. Jones RD,
    3. Videla R,
    4. Kania SA
    . 2012. Evaluation of cefoxitin disk diffusion breakpoint for detection of methicillin resistance in Staphylococcus pseudintermedius isolates from dogs. J Vet Diagn Invest 24:964–967. doi:10.1177/1040638712452112.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Arnold AR,
    2. Burnham CA,
    3. Ford BA,
    4. Lawhon SD,
    5. McAllister SK,
    6. Lonsway D,
    7. Albrecht V,
    8. Jerris RC,
    9. Rasheed JK,
    10. Limbago B,
    11. Burd E,
    12. Westblade LF
    . 2016. Evaluation of an immunochromatographic assay for rapid detection of penicillin-binding protein 2a in human and animal Staphylococcus intermedius group, Staphylococcus lugdunensis, and Staphylococcus schleiferi clinical isolates. J Clin Microbiol 54:745–748. doi:10.1128/JCM.02869-15.
    OpenUrlAbstract/FREE Full Text
  11. 11.
    1. Devriese LA,
    2. Vancanneyt M,
    3. Baele M,
    4. Vaneechoutte M,
    5. De Graef E,
    6. Snauwaert C,
    7. Cleenwerck I,
    8. Dawyndt P,
    9. Swings J,
    10. Decostere A,
    11. Haesebrouck F
    . 2005. Staphylococcus pseudintermedius sp. nov., a coagulase-positive species from animals. Int J Syst Evol Microbiol 55:1569–1573. doi:10.1099/ijs.0.63413-0.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
The Brief Case: Staphylococcus intermedius Group—Look What the Dog Dragged In
William Lainhart, Melanie L. Yarbrough, Carey-Ann D. Burnham
Journal of Clinical Microbiology Jan 2018, 56 (2) e00839-17; DOI: 10.1128/JCM.00839-17

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Brief Case: Staphylococcus intermedius Group—Look What the Dog Dragged In
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Brief Case: Staphylococcus intermedius Group—Look What the Dog Dragged In
William Lainhart, Melanie L. Yarbrough, Carey-Ann D. Burnham
Journal of Clinical Microbiology Jan 2018, 56 (2) e00839-17; DOI: 10.1128/JCM.00839-17
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • CASE
    • DISCUSSION
    • SELF-ASSESSMENT QUESTIONS
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

methicillin resistance
Staphylococcus intermedius group
Staphylococcus

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X